Editorial Board

Professor of Pathology and the Eugene McDermott Center for Human Growth and Development. He is also Clinical Director of the Advanced Diagnostics Laboratory at Children’s Health Dallas. His research and clinical interests are in genomics, gastrointestinal diseases, and immunoassays.

Professor of Laboratory Medicine and Pathology and co-Director of the Molecular Technologies Laboratory in the Department of Laboratory Medicine and Pathology. She is a member of several Clinical Genome Resource (ClinGen) working groups and expert panels. Her clinical and research interests are in genomic medicine, cardiovascular and connective tissue disorders, dyslipidemias, pharmacogenomics, and advanced genomic testing.

Professor of Medicine at Queen’s University Belfast, and Deputy Medical Director and Consultant Chemical Pathologist at Belfast Health and Social Care Trust. In addition, Chief Scientific Advisor to the Department of Health, Northern Ireland, and Director of Research for Health and Social Care. His main clinical and research interests are in nutrition and lipid metabolism, particularly in relation to cardiovascular disease. He is Past-President of the Association for Clinical Biochemistry and Laboratory Medicine, UK, and a previous Chair of the IFCC Scientific Division and the Joint Committee for Traceability in Laboratory Medicine (JCTLM). He is currently Chair of the UK Government’s Scientific Advisory Committee on Nutrition and the International Consortium for the Harmonization of Clinical Laboratory Results (ICHCLR).

Consultant medical biochemist at the Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital and the Norwegian Organization for Quality Improvement of Laboratory Examinations (NOKLUS). She is also Director of the Norwegian Porphyria Centre (NAPOS). Her main areas of expertise and research interests include the porphyrias, biological variation and its applications, external quality assessment and harmonization of the total testing process. She is chair of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Task Group for Biological Variation Database and the European Porphyria Network Laboratory Working Group, director of the European Porphyria Network External Quality Assessment Scheme and manager of the European Porphyria Registry.

Clinical Case Studies Co-Editor
Associate Professor of Medical Genetics and the Director of the Center for Genetics and Inherited Diseases at Taibah University. His major clinical and research interests involve the “Mendeliome” of consanguineous populations, candidate genes discovery and functional characterization, and laboratory developed tests and clinical validation. Raising the awareness of autosomal recessive diseases associated with consanguinity is one of his interests to reduce the burden of the inherited disorders.

Professor of Laboratory Medicine and Pathology at the University of Minnesota. In addition, he is Co-Medical Director of the Clinical and Forensic Toxicology Laboratory and, Principal Investigator of the CLIA certified Cardiac Biomarkers Trials Laboratory at the Hennepin Healthcare Research Institute, at Hennepin Healthcare/Hennepin County Medical Center. His research has focused on cardiac biomarkers involving acute coronary syndrome, heart failure, heart injury, and most recently COVID-19. He is a member of the ‘Universal Definition of Myocardial Infarction and Myocardial Injury’ Global Task Force, Chair of the IFCC Committee on Clinical Application of Cardiac Biomarkers, and member of the ADLM Academy Laboratory Medicine Practice Guidelines for Myocardial Infarction and Heart Failure.

Social Media Editor
Associate Professor of Laboratory Medicine and Director of the Clinical Chemistry Laboratory and fellowship program at Yale School of Medicine and Yale-New Haven Health. His interests including reducing preanalytical errors, biomarkers of kidney disease and injury, toxicology, mass spectrometry and science communication. He currently serves as Chair of the IFCC Committee on Kidney Diseases. He recently launched his own YouTube channel, titled “Clinical Chemistry with Joe El-Khoury,” that infuses science with comedy and is focused on changing laboratory medicine practice.

Associate Professor and Co-Director of Microbiology at the Mayo Clinic Arizona.  She was formerly the Director of the Infectious Disease Diagnostics Laboratory at the Children’s Hospital of Philadelphia and an Assistant Professor of Clinical Pathology at the Perelman School of Medicine at the University of Pennsylvania.  Dr. Graf completed her Ph.D. in Cell and Molecular Biology at The University of Pennsylvania studying HIV latency.  She then went on to complete an ASM accredited postdoctoral training program in medical and public health microbiology at ARUP Laboratories and the University of Utah.  Dr. Graf is board certified in medical microbiology.  Her research interests include the applications of next generation sequencing and metagenomics for diagnostic and epidemiologic investigations, as well as emerging rapid diagnostic technologies paired with diagnostic stewardship.

Professor of Laboratory Medicine, Head of the Division of Clinical Chemistry, and Director of Clinical Mass Spectrometry in the Department of Laboratory Medicine. His grant funded research focuses on using analytical chemistry to address hypotheses related to kidney disease, obesity, cancer, diabetes, Alzheimer's disease, and doping in sports. His laboratory also helps develop novel assays for the clinical laboratory that leverage the sensitivity and specificity of liquid chromatography-tandem mass spectrometry.

Reviews Co-Editor
Associate Professor in the Department of Laboratory Medicine and Pathology. She is the medical director of the University of Minnesota Masonic Children’s Hospital and Clinics laboratories and the Biochemical Genetics Laboratory at MHealth Fairview. She also serves as system director of point-of-care testing for MHealth Fairview. Her areas of expertise include the measurement of kidney filtration markers, and she has extensive experience directing or co-directing central laboratory testing for large clinical trials and multi-institutional research studies. She is the director of the Central Laboratory for the CKD-EPI research group. She is also Chair of the Point-of-Care Testing Committee for the College of American Pathologists, and is a member of the American Association for  Clinical Chemistry Evidence-Based Laboratory Medicine Subcommittee (EBLMS).

Clinical Case Studies Co-Editor

Consultant in Chemical Pathology in Manchester and honorary Professor of Clinical Biochemistry at Hull York Medical School. He was previously Division Chief in Clinical Biochemistry at Sidra Medicine in Doha, Qatar, and Consultant in Chemical Pathology at Hull Royal Infirmary as well as Professor of Pathology and Laboratory Medicine at Weill Cornell Medicine.

He is the previous Chair of the Science Committee of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and is a Past President of the UK’s Association for Clinical Biochemistry and Laboratory Medicine (ACB), now the Association for Laboratory Medicine. He has long-standing research interests in laboratory medicine and diabetes.

Reviews Co-Editor
Professor of Laboratory Medicine at AZ St. Jan Hospital in Bruges and Ghent University. His areas of interest and expertise are in lipidology and cardiovascular risk biomarkers. He is a member of the National Scientific Institute of Public Health (Sciensano, Belgium) Working Group Clinical Chemistry, Chair of the Science Committee of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM), and EFLM Representative for the European Atherosclerosis Society.

Professor of Laboratory Medicine and Pathology and Adjunct Professor of Genome Sciences. She is the Genetics Division Head and Director of the Genetics and Solid Tumor Diagnostics Laboratory in the Department of Laboratory Medicine and Pathology, and Clinical Director of the Northwest Genomics Center. Her expertise includes applying advanced molecular methods to detect genomic alterations in prenatal genetics, genetic disease, and oncology. She is currently Co-Investigator for several research studies, including national cell-free DNA programs, the Seattle Flu Alliance, and the NIH AllofUs program.

Associate Professor at Harvard Medical School, Associate Laboratory Director at Partners’ Laboratory for Molecular Medicine (LMM), Associate Cytogeneticist at Brigham & Women’s Hospital (BWH) Cytogenetics Laboratory, Program Director of the BWH Laboratory Genetics and Genomics (LGG) Training Program, and Site Training Director for the BWH Molecular Genetic Pathology fellowship program. She is also co-chair of the ClinGen RASopathy Variant Curation Expert Panel, which creates recommendations for using the ACMG/AMP sequencing variant classification guidelines when interpreting variants associated with the RASopathy disorders. In addition, she is an item writer for the American Board of Medical Genetics and Genomics (ABMGG) clinical genetics exam, LGG exam, and ABMGG MOC CertLink program, a member of the American College of Medical Genetics (ACMG) economics committee, and a book committee member for the 2023 and 2025 national ABMGG LGG exam.

Podcasts Editor
Associate Professor in the Department of Pathology and Laboratory Medicine and a Co-Director of Clinical Chemistry at Wisconsin Diagnostic Laboratories. His research interests include general clinical chemistry, maternal-fetal medicine, endocrinology and autoimmune encephalopathy.

Chairman of the Institute of Tumour Biology at the University Medical Center Hamburg-Eppendorf. The institute is part of the Centre of Experimental Medicine and the University Cancer Center Hamburg (UCCH). He is a pioneer in the fields of cancer micrometastasis, circulating tumor cells and circulating nucleic acids (ctDNA, microRNAs). He is also the founder and chairman of the European Liquid Biopsy Society (ELBS, www.elbs.eu) with partner institutions from academia, non-profit organizations and industry.

Q&A Editor
Assistant Professor in the Department of Clinical Pathology and Laboratory Medicine at the University of Pennsylvania Perelman School of Medicine and Medical Director of Clinical Chemistry and Point-of-Care testing at the Children’s Hospital of Philadelphia. Her areas of interest include emerging biomarkers and IVD technologies as well as pediatric clinical chemistry, lab stewardship and informatics.

Clinical Case Studies Co-Editor
Assistant Professor in Pathology at Harvard Medical School, and Director of the Biochemical Genetics Laboratory and Associate Director of Clinical Chemistry at Boston Children’s Hospital. His clinical service, teaching and research interests are focused on inborn errors of metabolism, and the application of metabolomic profiling towards the study of genetic metabolic disorders.

Senior Investigator and Chief of Clinical Chemistry at the National Institutes of Health. His research interests are in intracellular signal transduction. His primary clinical focus is on diabetes mellitus, with an emphasis on the interface between the clinical laboratory and patient care.

Previous Professor of Pathology and Immunology in the Division of Laboratory and Genomic Medicine and Medical Director of Clinical Chemistry and Point of Care Testing at Barnes-Jewish Hospital. He retired July 2021 and is now an Adjunct Professor.

Perspectives Editor
Associate Professor of Laboratory Medicine and Pathology, and is a co-director in the Protein and Antibody Immunology Laboratories and the Clinical Mass Spectrometry Laboratory. She is program director of the post-doctoral clinical chemistry fellowship program in the Department of Laboratory Medicine and Pathology at Mayo Clinic. Her research projects span four areas related to protein testing and immunology: laboratory testing for the monoclonal gammopathies, analysis of immunoglobulins free light chains in serum and in cerebrospinal fluid, the complement system and development of methods of detection for monoclonal antibody therapeutics using mass spectrometry. She is Vice-Chair of the Diagnostic Immunology and Flow Cytometry committee of the College of American Pathologists, and is Chair for the Clinical and Diagnostic Immunology Division of ADLM.

Professor Emeritus of Pathology at the University of Utah. His expertise includes technique and instrument development in molecular diagnostics; he developed and was a primary inventor of the first rapid PCR (15 min) systems. He introduced advances such as SYBR Green, hybridization probes, and melting analysis to real-time PCR. He continues to develop methods in extreme PCR (< 1 min) and high-speed melting (<5 s).

Associate Professor in the Department of Pathology and Laboratory Medicine, Medical Director of Clinical Chemistry and Toxicology Laboratory, and Co-Director of the ComACC accredited Clinical Chemistry Fellowship Program at New York-Presbyterian Hospital/Weill Cornell Medicine. She is board certified in both Clinical Chemistry and Toxicological Chemistry by ABCC. Her clinical and research interests are artificial intelligence, machine learning, clinical mass spectrometry, and toxicology/TDM. She currently serves as the Chair of Artificial Intelligence Working Group in the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), and is a member in the ADLM Academy Council, Education Core Committee, and Data Analytics Steering Committee.

Associate Professor of Pathology & Immunology at Washington University in St. Louis and the medical director of clinical chemistry and point-of-care testing at Barnes Jewish Hospital. His research interests include prognostication of disease using cardiac biomarkers, laboratory testing at the host-pathogen interface, and preanalytical errors in laboratory testing.